We noticed you’re blocking ads

Thanks for visiting MillennialEYE. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://millennialeye.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Cover Focus | May/June '16

What’s New, What’s Next

Glaucoma specialists describe the most exciting developments in their space.

author
Ike Ahmed, MD
Ike Ahmed, MD
  • Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship at the University of Toronto
  • Clinical Assistant Professor at the University of Utah in Salt Lake City
  • ike.ahmed@utoronto.ca
  • Financial interest: None acknowledged
author
Keith Barton, MD, FRCP, FRCS, FRCOphth
Keith Barton, MD, FRCP, FRCS, FRCOphth
  • Consultant in the Glaucoma Service at Moorfields Eye Hospital in London
  •  Honorary Reader at University College London’s Institute of Ophthalmology
  • Chairman, International Glaucoma Association
  • keith@keithbarton.co.uk
  • Financial disclosure: Lecture fees (Allergan, Pfizer); Advisory board (Alcon, Amakem, Glaukos, Ivantis, Kowa, Merck, Refocus, Thea); Consultant (Alcon, Aquesys, Carl Zeiss Meditec, Kowa, Ivantis, Refocus, Santen, Transcend Medical)
author
Robert Noecker, MD, MBA
Robert Noecker, MD, MBA
  • Assistant Clinical Professor of Ophthalmology, Yale University School of Medicine, New Haven, Connecticut
  • Clinical Professor of Surgery, Frank Netter School of Medicine, Quinnipiac University, New Haven
  • Director of Glaucoma, Ophthalmic Consultants of Connecticut
  • noeckerrj@gmail.com
  • Financial interest: None acknowledged
author
Nathan Radcliffe, MD
Nathan Radcliffe, MD
  • Director of Glaucoma, NYU Langone Ophthalmology Associates, New York University, New York
  • drradcliffe@gmail.com
  • Financial interest: None acknowledged
author
Arsham Sheybani, MD
Arsham Sheybani, MD
  • Assistant Professor of Ophthalmology and Visual Sciences, Washington University School of Medicine in St. Louis, Missouri
  • sheybaniar@vision.wustl.edu; Twitter @Arsham_Sheybani
  • Financial disclosure: Consultant

NEXT IN THIS ISSUE